06Mar/13

India rejects plea against cancer drug – Boston Globe


Boston Globe

India rejects plea against cancer drug
Boston Globe
Last year, India’s patent office allowed local drug manufacturer Natco Pharma Ltd. to produce a generic version of Bayer’s kidney and liver cancer drug Nexavar on the grounds it would make the drug available to the public at a reasonably affordable price.
Enter compulsory licensingBusiness Standard
Indian patent appeal board upholds compulsory license on Bayer’s NexavarThe Pharma Letter
IPAB rejects Bayer’s appeal on the grant of Compulsory LicenseLexology (registration)
Morning Star Online –Newstalk ZB
all 52 news articles »
05Mar/13

Dhoni opens his heart out after being declared India's most successful Test … – India Today


India Today

Dhoni opens his heart out after being declared India’s most successful Test
India Today
A second successive win over Australia here on Tuesday made captain Mahendra Singh Dhoni open his heart and make a few admissions on a day he became India’s most successful Test captain with 22 victories. But Dhoni played down his achievement
Clarke’s hand forced as Australia loses second Test to India by an innings and Herald Sun
Cheteshwar Pujara-Murali Vijay stand set up the win, says MS DhoniIBNLive
Not the second Rahul Dravid, but the first Cheteshwar PujaraCricket Country
NDTV –Wisden India –The Hindu
all 779 news articles »
05Mar/13

Indian patent appeal board upholds compulsory license on Bayer's Nexavar – The Pharma Letter


Newstalk ZB

Indian patent appeal board upholds compulsory license on Bayer’s Nexavar
The Pharma Letter
grant of a compulsory licence has now been issued by India’s Intellectual Property Appellate Board (IPAB) in Chennai, upholding the March 2012 granting of the first compulsory license for the firm’s kidney and liver cancer drug Nexavar (sorafenib
India rejects German transnational’s cancer drug patent appealMorning Star Online
Landmark ruling against patent drugs in IndiaNewstalk ZB
India Rejects Bayer Plea Against Cheap Cancer DrugPharmaceutical Processing

all 50 news articles »